ADPT Stock: Price, Earnings History and SEC Filings
Adaptive Biotechnologies Corporation (ADPT) last traded at $26.64, down 5.43% on the latest session and down 7.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.10 against an analyst estimate of $-0.13, a beat of 23.1%.
$26.64 -5.43%
1 month-7.82%
52-week high$30.74
52-week low$12.00
Volume4.26M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ADPT earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 29, 2026 | $-0.10 | $-0.13 | +23.08% |
| Mar 2026 | May 5, 2026 | $-0.13 | $-0.16 | +18.75% |
| Dec 2025 | Feb 5, 2026 | $-0.09 | $-0.19 | +52.63% |
| Sep 2025 | Nov 5, 2025 | $-0.15 | $-0.16 | +6.25% |
ADPT beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for ADPT
SEC filing data is not available right now. You can search for ADPT on SEC EDGAR.
ADPT news
- TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation SequencingOct 29, 2026 · finance.yahoo.com
- Can You Still Buy Tempus AI Stock Today?Oct 28, 2026 · trefis.com
- Adaptive Biotechnologies Corp. (ADPT) Rallies on Earnings Beat, Raised Outlook, and Cash-Flow TargetsOct 27, 2026 · finance.yahoo.com
- What Happens To Tempus AI Stock If Its Cash Burn Continues?Oct 26, 2026 · trefis.com
- Should You Be Worried About Tempus AI Stock?Oct 20, 2026 · trefis.com
About Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation (ADPT) is a US-listed public company on Nasdaq.